Breaking News

You are here » Indian-Commodity  :  Corporate  :  GAIL reports around 4-fold jump in Q4 net profit

25-May2018

GAIL reports around 4-fold jump in Q4 net profit

GAIL India has reported results for the fourth quarter and year ended March 31, 2018.

The company has reported around 4-fold jump in its net profit at Rs 1020.92 crore for the quarter ended March 31, 2018 as compared to Rs 260.16 crore for the same quarter in the previous year. Total income of the company increased by 11.06% at Rs 15706.27 crore for quarter under review as compared to Rs 14141.80 crore for the quarter ended March 31, 2017.

For the year ended March 31, 2018, the company has posted a rise of 31.84% in its net profit at Rs 4618.41 crore as compared to Rs 3502.91 crore for the previous year. Total income of company increased by 9.50% at Rs 54812.49 crore for year under review as compared to Rs 50059.26 crore for the year ended March 31, 2017.


Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......